| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a3c3c5d2c2fa345578675969e59dd45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec2cf2772a722c89d7cdeaf3f7f441cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4df108cb4c2f6009ddbfe8c1e3093cd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-71 |
| filingDate |
2007-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4c08b6e4e2a3d173e548dae0b934482
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4efd329c2a0a0e62bd548cf53679e499
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_000796f43b4c0990727cd0b42c5086fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6956a4b59f5354525b61823048e2e44a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb7a38ba903c6bdf62ffb1ec6219e297
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60f04d53a1d109809d03fd93959f3f6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd5d263a5634dbad3ff3e204ecc0b6e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbd56ceb2e785e329b0c39a5feb98972 |
| publicationDate |
2009-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2054440-A2 |
| titleOfInvention |
Peptide derived from vascular endothelial growth factor receptor-1 binding integrin 5 1, having proangiogenic activity |
| abstract |
Description of a sequence peptide isolated in the domain II type-immunoglobulin (Type-Ig) of the Vascular Endothelial Growth Factor receptor 1 (VEGF-1) binding integrin α5β1, usable for the preparation of pharmacological agents having proangiogenic activity. |
| priorityDate |
2006-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |